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Introduction
Dementia is a syndrome of  progressive impairment in one 
or more areas of  cognition. These include memory, language, 
abstract thinking, praxis, perceptual skills, personality, as well 
as social behaviour. The cognitive aberrations of  dementia 
usually represent a significant decline from previous 
baseline capacities, and they interfere with work, social 
function, relationships and independence in activities of  
daily living.  The prevalence rises from about 1-2% at age 
65 to 10-15% at age 80, and may be as high as 40% by age 
90.1 Neurodegenerative conditions like Alzheimer’s disease 
and frontotemporal lobar degenerations are, by far, the 
commonest causes of  dementia.2 They usually have a poor 
prognosis given that there is currently no curative treatment 
for this disorder, and existing symptomatic drugs only have 
limited effects.3 However, there are also several treatable 
diseases that can lead to dementia with a more or less rapid 
course.4,5 This case report aims to emphasize the need to 
actively look for treatable causes in patients presenting with 
dementia, especially when there are some atypical clinical 
features.
Case presentation
A 42-year-old woman presented in the emergency department 
with a 6-month history of  diffuse headache of  moderate 
intensity. Over a course of  3 months, she also had gradual 
onset of  imbalance, generalized weakness, hypophonia, 
apathy, dysphagia, constipation and urinary incontinence. 
The guardians reported a change in her personality over the 
previous years with frequent episodes of  incoherent speech 
and memory decline.  Her maternal aunt had early-onset 
cognitive decline and died before the age of  50. There was 
no history of  head trauma or fluid leakage through the ear, 
the nose or the throat. The following symptoms were absent: 
seizures, hallucinations, vomiting, diplopia, blurred vision, 
agitation, and sensory loss.
On admission, she was afebrile and bedridden. The 
neurological examination identified a severe apathy with 
motor impersistence, marked primitive reflexes (sucking, 
palmomental, and Babinski sign), generalized hyperreflexia 
with bilateral Hoffman sign and ankle clonus but no limb 
spasticity, an effortful but comprehensible speech, and 
frequent startles. There was no papillary oedema on the 
fundoscopy. Because of  the severe apathy and somnolence, 
it was not possible to perform a more precise evaluation of  
the olfaction, the higher order cerebral functions, and the 
motor and sensory pathways.
Given the limited resource available, the patient underwent 
a minimal biological workup. The full blood count, the liver 
and thyroid function tests and the HIV and syphilis screening 
tests were unremarkable. The cerebrospinal fluid analysis 
revealed a high protein level (1.9 g/L) with normal cell 
count, microscopy and culture. The kidney function could 
not be assessed for technical reasons. A brain computed 
tomography (CT) scan without contrast (unknown creatinine 
level) revealed a large irregular paramedian subfrontal extra-
axial mass, slightly hyperdense with some calcifications and 
a local mass effect, with effacement of  frontal sulci (Figure 
1A).
The radiological features were suggestive of  an olfactory 
groove meningioma. The patient had a neurosurgical 
resection of  the tumour (shown in Figure 1B) leading to a 
significant improvement of  her symptoms. The histological 
examination confirmed a grade I meningothelial meningioma. 
There was no immediate post-operative complication. The 
post-operative MRI confirmed the complete resection of  the 
tumour and the re-expansion of  the frontal lobes (Figures 
1C and 1D). The post-operative follow-up was uneventful 
and the patient was asymptomatic and independent 6 weeks 
after the surgery.
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A 42-year-old woman presented with a 6-month history of  diffuse headache of  moderate intensity and gradual onset of  generalized 
weakness, imbalance, apathy, memory decline, hypophonia, dysphagia, constipation and urinary incontinence. Clinical examination 
revealed several elements of  a frontal lobe dysfunction including apathy with motor impersistence, presence of  primitive reflexes, 
generalized hyperreflexia with bilateral Hoffman sign and ankle clonus. The biological workup was unremarkable and a brain 
computed tomography scan identified a giant olfactory groove meningioma. A prompt neurosurgical intervention helped to reverse 
the symptoms. This case illustrates the benefits of  actively looking for treatable conditions in young patients presenting with acute or 
subacute dementia and emphasizes the pivotal role of  early brain imaging.
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Discussion
This patient presented with a dementia (progressive 
impairment of  memory, social behaviour and personality 
with loss of  independence) associated with signs of  frontal 
lobe dysfunction (apathy, hypophonia, dysphagia, urinary 
incontinence, motor impersistence, marked primitive 
reflexes and generalized hyperreflexia). In the context 
of  a positive family history for early-onset dementia, the 
diagnosis of  fronto-temporal dementia (FTD) could be 
proposed. The latter is considered as the second most 
common cause of  early onset dementia (before the age of  
65), second only to Alzheimer’s disease.6 Approximately 
40% of  FTD is associated with an autosomal dominant 
pattern of  inheritance.7 However, given the young age, the 
presence of  headache and the rapid progression leading to 
severe disability in less than a year, other non-degenerative 
and potentially treatable conditions needed to be discussed.5 
These conditions include brain tumours involving the frontal 
lobe (especially parafalcine or olfactory groove meningiomas 
with symmetrical involvement of  both frontal lobes and 
compression of  the micturition control centre in the medial 
frontal cortex), auto-immune encephalitis,  hydrocephalus 
(obstructive or normal pressure; the latter typically causes 
gait instability, urinary incontinence and dementia [Hakim-
Adams’ triad]), infectious diseases (HIV-associated 
neurocognitive decline, neurosyphilis, sporadic Creutzfeldt-
Jakob disease), chronic post-traumatic lesions (subdural 
hematoma), metabolic diseases (e.g. hypothyroidism), and 
depression. Reversible dementia has also been reported with 
various drugs, notably anticholinergics, benzodiazepines, 
antidepressants, steroids, opiates, non-steroidal anti-
inflammatory drugs and histamine H2 receptor antagonists.8 
In this case, a well selected set of  paraclinical examinations 
helped to quickly identify a giant olfactory groove 
meningioma as the cause of  the dementia and to provide 
the appropriate treatment in order to reverse the symptoms.
Meningiomas are the most common meningeal tumours and 
represent more than 20% of  all intracranial tumours.9 They 
usually affect women in their fifth decade. Neurofibromatosis 
type 2,10 irradiation,11 hormone replacement therapy,12 and 
foreign bodies13 are classical risk factors  but were not 
present in our case. Head trauma has also been suspected 
as a risk factor for meningiomas in case-reports and case-
control studies but the association is not confirmed in 
population-based cohorts.14,15 This suggests the influence 
of  a recall bias in case-control studies. Meningiomas can be 
found in all locations but 60% of  meningiomas are either 
parasagittal (inserted on the falx) or located on the convexity. 
The olfactory groove location is observed in less than 10% 
of  cases.16 When meningiomas are slow growing and located 
in the anterior frontal region as is the case in our patient, the 
diagnosis is frequently delayed. This happens because focal 
neurological deficits are often absent and the intracranial 
pressure is only slightly elevated if  at all. Moreover, in some 
patients, a chronic papilledema might be difficult to identify 
on fundoscopy due to secondary optic nerve atrophy.
Olfactory groove meningiomas frequently present as pseudo-
dementia resulting from subacute or chronic compression 
of  the frontal lobe.16 This chronic compression of  the 
central nervous system might induce a high protein level 
in the cerebrospinal fluid, a non-specific finding frequently 
reported with spinal cord compressions. The sensitivity 
of  a brain CT scan for the diagnosis is almost 100%.9 
Meningiomas typically appear as hyperdense or isodense 
extra-axial lesions, inserted on the meninges, with inconstant 
calcifications and homogeneous contrast enhancement. 
Associated bone lesions are frequently found, notably 
hyperostosis or osteolysis.9,17 Meningiomas are most often 
benign and surgical treatment is usually associated with very 
good prognosis and very low recurrence rate.
This case illustrates the benefits of  actively looking for 
treatable conditions in young patients presenting with acute 
or subacute dementia. It also emphasizes the role of  early 
brain imaging. In resource-limited settings where careful 
selection of  complementary examinations is mandatory, 
investigation of  dementia should always include brain 
imaging as soon as possible, unless there are other obvious 
infectious, hemodynamic or metabolic emergencies.
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Figure 1: Olfactory groove meningioma – pre- and post-operative images  
A: Preoperative axial brain computed tomography (CT) scan slice (without contrast) showing the olfactory 
groove meningioma as an extra-axial hyperdense mass with a small calcification (black arrow). There is 
significant perilesional oedema in the frontal lobes (white asterisks) and evidence of mass effects on the 
anterior horns of the lateral ventricles. B: Macroscopic view of the meningioma freshly excised. The bowl 
has the shape of a truncated cone (outlet inner diameter: 16 cm, base diameter: 11 cm, depth: 6 cm). 
C: Post-operative axial brain T2 magnetic resonance imaging (MRI) slice showing the complete resection of 
the olfactory groove meningioma (black asterisk). The lateral ventricles have recovered their normal shape.  
The frontal bone flap was not tightly fixed back for safety reasons. This explains the presence of a 
subcutaneous cerebrospinal fluid pouch (black arrow head). D: Post-operative sagittal brain T1 MRI slice 
also showing the complete resection of the olfactory groove meningioma (white arrow head) and the normal 
re-expanded frontal lobe.
Figur : Olfacto y groove meningioma – pre- and post-operative 
images
A: Preoperative axial brain computed tomography (CT) sca  slice (without contrast) 
showing the olfactory groove meningioma as an extra-axial hyperdense mass with a small 
calcification (black arrow). There is significant perilesional oedema in the frontal lobes 
(w ite s e isks) and evidence of mass effects on the anterior horns of the late al ventricles. 
B: Macroscopic view of the meningioma freshly excised. The bowl has the shape of a 
truncated cone (outlet inner diameter: 16 cm, base diameter: 11 cm, dept : 6 cm). 
C: Post-operative axial brain T2 magnetic resonance imaging (MRI) slice showing the 
complete resection of the olfactory groove meningioma (black asterisk). The lateral 
ventricles have recovered their normal shape.  The frontal bone flap was not tightly fixed 
back for safety reasons. This explains the presence of a subcutaneous cerebrospinal fluid 
pouch (black arrow head). D: Post-operative sagittal brain T1 MRI slice also showing 
the complete resection of the olfactory groove meningioma (white arrow head) and the 
normal re-expanded frontal lobe.
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